Mortgage Blog
Community bank pledges to put people first
In the world of business, the saying “success is all about people helping people” holds truer than ever. Derrick Roberts, the owner of Stan Weaver and Company, knows this firsthand.
Stan Weaver and Company is a manufacturers rep for heating and air conditioning for the HVAC industry founded in Tampa Bay. “We sell the equipment to the mechanical contractor who installs it that day,” Roberts said.
Roberts further explained his growth and where his passion for his people came from, “It started…
Activist investor Starboard targets $3B Durham CRO Fortrea
Starboard Value's CEO thinks the contract-research industry is poised for long-term growth.
Fox Chase Cancer Center invests in radiopharmaceuticals startup
The collaborators are exploring the creation of a radiopharmaceutical manufacturing plant in Philadelphia.
Lucid’s stock falls 5% after its production slumped
The electric vehicle maker produced fewer vehicles from its Arizona manufacturing plant than it did in the previous quarter and in the year-ago period.
Ardelyx dialysis drug approved by FDA after appeal
The U.S. Food and Drug Administration has given the green light to a Waltham biotech's dialysis drug, just over two years after initially rejecting it.
Lucid’s stock fell 5% after its production slumped
The electric vehicle maker produced fewer vehicles than it did in the previous quarter and in the year-ago period.
Lower headcount remains a key to Bank of America’s expense strategy
Bank of America executives foresee another quarterly decline in noninterest expenses on the horizon.
TrustCo Bank names new board member
Trustco Bank Corp NY's board of directors elected a new member this week.
A gene therapy for Alzheimer’s Disease? North Bay rare disease pioneer hopes to spin out company to do it
CEO Emil Kakkis said spinout Amlogenyx could raise its Series A round by the end of the year with Ultragenyx keeping a majority stake.
Peninsula biotech’s stock soars as it cuts staff, focuses cell therapy on autoimmune diseases
The company's stock finished Tuesday 110% higher after it outlined plans to cut staff by 10%, extend its cash runway and focus on diseases like lupus.